2,3-Dihydro-4-phenyl-1H-1,5-benzodiazepine CAS 20927-57-5

Description

The occurrence of 2,3-Dihydro-4-phenyl-1H-1,5-benzodiazepine is closely related to a nitrogen-containing heterocyclic scaffold, a nitrile group in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.

CATO supplies 2,3-Dihydro-4-phenyl-1H-1,5-benzodiazepine (CAS 20927-57-5), a certified reference material (molecular formula C15H14N2, MW 222.29 g/mol) for analytical method development and quality control.

Owing to a nitrogen-containing heterocyclic scaffold, a nitrile group, 2,3-Dihydro-4-phenyl-1H-1,5-benzodiazepine is typically pale yellow to yellow low-melting solid. Its solid-state physicochemical attributes — including a molecular weight of 222.29 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com